Best pharmaceutical companies in Princeton, NJ

Ranbaxy Pharmaceuticals, Inc. markets prescription and generic pharmaceutical products in the United States. Its product line includes anti-infective, cardiovascular, non-steroidal anti-inflammatory, anti-expectorant, analgesic, gastrointestinal, and central nervous system products, as well as controlled substances. The company was incorporated in 2004 and is based in Princeton, New Jersey. Ranbaxy Pharmaceuticals, Inc. is a subsidiary of Ranbaxy Inc.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited, of Hyderabad, India.

Kremers Urban Pharmaceuticals Inc. is a pharmaceutical company that delivers the product solutions and dedicated customer service needed to get specialty generic products to market without all the perplexity.

Covance Inc. is a global contract research organization recognized for being the world's most comprehensive drug development company. It has a team of professionals that are dedicated to advancing healthcare and delivering fast and innovative medical solutions to patients and healthcare providers. The company also offers laboratory testing services to the chemical, agrochemical, and food industries. It is also a market leader in central laboratory, toxicology, and discovery services.

Choose a country on the map to see corporate head office contact information including address, phone number and website.

Certara is the leading biosimulation and regulatory writing consultancy, focused on optimizing and increasing the predictability of the most crucial R&D, regulatory and patient care decisions. We provide a wide range of products, services and solutions that enable our clients to achieve key drug development milestones. Our portfolio spans the discovery, preclinical, clinical and post-marketing phases of drug development, working with 1,200 commercial companies, 250 academic institutions and numerous regulatory agencies.

Cytogen is a biopharmaceutical company that is focused on the development and building of pharmaceutical products for cancer patients. Cytogen markets QUADRAMET, PROSTASCINT, CAPHOSOL, and SOLTAMOX. It also develops CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. Cytogen was acquired by EUSA Pharma in May 2008. Cytogen was founded by Thomas J. McKearn in 1980. It is based in Princeton, New Jersey.

iMEDGlobal is a global CRO specialized in regulatory affairs, product safety and toxicology, medical affairs and technology, and clinical operations for biopharmaceutical, medical device, and consumer healthcare industries.

Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, their respected family-owned Swiss parent company has pioneered technological advances that make regenerative treatment, with safe and naturally sourced biomaterials, the preferred choice for clinical predictability.

Choose Quartesian for clinical data management, statistical programming, and medical writing services with unbeatable speed, cost, and quality.

KBP is a world-class biotechnology research & development organization dedicated to providing innovative therapies for unmet medical needs.

Slayback is founded on the principle of “connecting the dots”. This principle translates into their philosophy of connecting one idea with another. The idea is to conceptualize and develop complex generic and specialty drugs. They focus on products that are challenging and highly complex to develop and/or manufacture. It could be a complex oil-in-water emulsion or a sterile long acting injectable using nano-spheres or sterile suspensions with complex particle physics. They have also worked on complex hormonal products with challenging cross-contamination issues. They aim to optimize the use of technology and potential (generated from a strong experience in this field) to develop a value proposition for their customers. Through this process of drug development, they remotely aim at reducing the cost of therapy by bringing expensive branded drugs within the reach of patients.

Soterius provides outsourced clinical safety, pharmacovigilance, medical affairs, and technology-enabled services and solutions. It is a trusted name in the life sciences industry for providing integrated outsourced drug safety and pharmacovigilance, medical affairs, and medical writing services with a customer base spanning Top 10 pharmaceutical companies, biopharmaceutical companies, global cosmetics conglomerates, and generic drug manufacturers. Soterius supports life sciences companies through their drug development, approval, and commercialization processes, helping them find and deploy an optimal mix of outsourced and in-house operations.

Ethypharm, a specialty pharma with European roots, focused on the Central Nervous System (CNS) and Critical Care.